GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $318,000 | -13.6% | 7,298 | -13.6% | 0.22% | -5.6% |
Q1 2022 | $368,000 | -7.5% | 8,451 | -6.3% | 0.23% | -8.2% |
Q4 2021 | $398,000 | +15.4% | 9,023 | +0.0% | 0.26% | +2.4% |
Q3 2021 | $345,000 | -5.2% | 9,020 | -1.3% | 0.25% | -4.2% |
Q2 2021 | $364,000 | +10.0% | 9,135 | -1.5% | 0.26% | +1.2% |
Q1 2021 | $331,000 | -5.2% | 9,275 | -2.2% | 0.26% | -12.3% |
Q4 2020 | $349,000 | – | 9,488 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |